|
BR122021024397A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR202018014992U2
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003521A2
(enExample)
|
|
|
|
BR202017025154U2
(enExample)
|
|
|
|
BR202017021228U2
(enExample)
|
|
|
|
BR202017020981U2
(enExample)
|
|
|
|
BR202017004898U2
(enExample)
|
|
|
|
BR102017003115A2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN303998285S
(enExample)
|
|
|
|
CN303892649S8
(enExample)
|
|
|
|
CN304001995S
(enExample)
|
|
|
|
CN304000095S
(enExample)
|
|
|
|
CN304002557S
(enExample)
|
|
|
|
CN304003979S
(enExample)
|
|
|
|
CN303995600S
(enExample)
|
|
|
|
CN303995552S
(enExample)
|
|
|
|
CN303949240S9
(enExample)
|
|
|
|
CN303948614S9
(enExample)
|
|
|